Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -61,424 | -26,791 | -75,808 | -58,096 | -38,184 |
| Depreciation Amortization | 384 | 180 | 749 | 563 | 378 |
| Accounts receivable | -179 | -97 | 860 | 719 | 759 |
| Accounts payable and accrued liabilities | 2,754 | 4,709 | 5,213 | 3,379 | 1,960 |
| Other Working Capital | -2,568 | -654 | 4,501 | 1,400 | 932 |
| Other Operating Activity | 11,354 | 6 | -2,109 | 3,469 | 2,901 |
| Operating Cash Flow | $-49,679 | $-22,646 | $-66,594 | $-48,567 | $-31,254 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -643 | -402 | -744 | -636 | -463 |
| Investing Cash Flow | $-643 | $-402 | $-744 | $-636 | $-463 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 708 | 686 | 139,394 | 714 | 577 |
| Other Financing Activity | 0 | 0 | -9,411 | 0 | 0 |
| Financing Cash Flow | $708 | $686 | $129,983 | $714 | $577 |
| Exchange Rate Effect | -8,690 | -1,810 | 4,503 | -1,869 | -1,501 |
| Beginning Cash Position | 198,344 | 192,177 | 132,404 | 133,528 | 135,156 |
| End Cash Position | 140,039 | 168,006 | 199,552 | 83,170 | 102,515 |
| Net Cash Flow | $-58,305 | $-24,171 | $67,149 | $-50,358 | $-32,641 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,679 | -22,646 | -66,594 | -48,567 | -31,254 |
| Capital Expenditure | -643 | -402 | -744 | -636 | -463 |
| Free Cash Flow | -50,323 | -23,048 | -67,338 | -49,203 | -31,717 |